Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit

Core Insights - Pharming Group N.V. is participating in the Oppenheimer Movers in Rare Disease Summit on December 11, 2025, in New York City, focusing on innovative companies and investors in the rare disease sector [1] - Anurag Relan, M.D., Chief Medical Officer of Pharming, will engage in a discussion about the hereditary angioedema (HAE) market during the event [1] Company Overview - Pharming Group N.V. is a global biopharmaceutical company dedicated to developing and commercializing innovative medicines for patients with rare, debilitating, and life-threatening diseases [3] - The company is headquartered in Leiden, the Netherlands, with a significant number of employees based in the U.S. [3]